Valued at a market cap of $172.5 billion, Intuitive Surgical, Inc. (ISRG) is a medical technology company that develops and markets robotic-assisted surgical systems, instruments, and related digital solutions used in minimally invasive procedures. The California-based company provides surgical robots, instruments, accessories, and training to hospitals and surgeons worldwide. This global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery has struggled to keep up wit ...

Core Insights - Intuitive Surgical reported strong fourth-quarter earnings and revenue, surpassing analyst expectations, driven by growth in da Vinci and Ion procedures [1][2] Financial Performance - Adjusted earnings per share reached $2.53, exceeding the consensus estimate of $2.26 [1] - Revenue increased to $2.87 billion, surpassing expectations of $2.75 billion, marking a 19% rise from $2.41 billion in the same quarter last year [1] Procedure Growth - Da Vinci procedures grew by 17%, while Ion procedures saw a significant increase of 44% during the quarter [2] - The company placed 532 da Vinci systems in the quarter, up from 493 a year earlier, expanding the installed base to 11,106 systems, a 12% year-over-year increase [2] Revenue Breakdown - Revenue from instruments and accessories rose 17% to $1.66 billion [2] - Systems revenue increased to $786 million from $655 million in the prior-year quarter [2] Future Outlook - The company forecasts worldwide da Vinci procedure growth of approximately 13% to 15% in 2026, a decrease from 18% growth projected for 2025 [3] - Intuitive Surgical anticipates a non-GAAP gross profit margin of 67% to 68% of revenue, factoring in an estimated 1.2 percentage point impact from tariffs [3]